Specializing in new chemical substance, cosmetics, and medical device registration for over 12 yearsLearn More

Cosmetics News

Professional regulatory updates and insights

Hainan Publishes a Filing Guide for General Cosmetics

General cosmetics filing starts with the correct entity, route and dossier

Filer eligibility and market-entry routes

Hainan’s medical products regulator has issued a guide for general cosmetics filing. A filer must be a legally established enterprise or organization with a suitable quality-management system and adverse-reaction monitoring capability, and must appoint a qualified person responsible for quality and safety. Domestic general cosmetics are filed with the provincial regulator where the filer is located before sale; imported general cosmetics are filed with the State Council’s medical products regulator before import, subject to delegated arrangements.

Core filing materials

A general cosmetics filing normally includes the application form, product name and naming basis, formula or full ingredient list, applicable standard, label draft, testing report and safety-assessment materials. A first-time filer must also provide evidence of eligibility. Imported products need proof of sale in the country or region of manufacture and evidence that the overseas manufacturer meets applicable quality requirements; products made solely for export to China follow the guide’s additional research and testing requirements.

Account role determines platform permissions

The platform supports registrant or filer, domestic responsible person and manufacturer roles. Registrants or filers may file products made in-house or by contractors; domestic responsible persons may file imported products for overseas entities; manufacturers may file only contracted-production or export products. Companies first register a corporate account on the NMPA government service portal, bind the cosmetics filing information platform and submit the role-specific entity materials.

Annual reporting and public disclosure continue

Filers must report production, import and continuing compliance by March 31 each year. After filing is completed, the regulator should publish the filing information within five working days. Regulix recommends maintaining a checklist by product type, account role and production model, and reconciling formula, labels, testing and safety-assessment materials before submission.

Official Source: Hainan Provincial Medical Products Administration

This article was prepared by Regulix based on publicly available information from official sources and includes our regulatory compliance analysis to help companies better understand the applicable requirements and their potential impact.

Need Professional Support for China Regulatory Compliance?

Regulix provides professional registration, filing and compliance consulting for chemicals, cosmetics and medical devices in China.

Contact Our Experts
Explore Our Insights

News Categories